Status:
NOT_YET_RECRUITING
DEX vs SEVO in Congenital Heart Surgery
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Heart Defects, Congenital
Eligibility:
All Genders
1-3 years
Phase:
PHASE4
Brief Summary
Anesthesia-related neurotoxicity in the developing brain is still a concern although evidence in humans is debatable. Moreover, it is unclear whether repeated and/or prolonged exposures are harmless a...
Eligibility Criteria
Inclusion
- Patients up to 3 years
- Must undergo cardiac surgery with CPB
Exclusion
- Preoperative chronic kidney disease (glomerular filtration rate of less than 30 ml/min per 1.73m2 for greater than 3 months)
- Preoperative cerebral hemorrhage, stroke or
- Preoperative seizures
- Abnormal preoperative cerebral ultrasound
- Preoperative Extracorporeal Life Support
- Preoperative sedated and intubated patients
- Preterm newborns (\< 32 W gestational age)
- Newborns weighing \< 2 kg
- Patients with Williams-Beuren syndrome.
Key Trial Info
Start Date :
January 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05369949
Start Date
January 5 2023
End Date
June 30 2026
Last Update
September 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.